Biopharma Business

Tag "Sanofi Pasteur"

Back To Homepage Subscribe To RSS Feed

MedImmune and Sanofi Pasteur form alliance to develop and commercialise potential next-generation respiratory syncytial virus antibody MEDI8897

MedImmune, the global biologics research and development arm of AstraZeneca, and Sanofi Pasteur, the vaccines division of Sanofi, have announced an agreement to develop and commercialise MEDI8897 jointly. MEDI8897 is

Read Full Article

Sanofi and AstraZeneca to Collaborate on Antibody for Prevention of Respiratory Illnesses

Sanofi and its vaccines global business unit Sanofi Pasteur announced today an agreement with MedImmune, the global biologics research and development arm of AstraZeneca, to develop and commercialize a monoclonal antibody–called MEDI8897–for the

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here

Advertisements



 Breaking News
  
© 2017 Copyright Premier Publishing. All Rights reserved.
Designed by PREMIER PUBLISHING
Designed by Orange Themes

Loading..

Close Window

Loading, Please Wait!

This may take a second or two.